简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2019-10-11 12:44 Project Management Institute Announces the Top 50 Most Influential Projects of the Last 50 Years
2019-10-11 12:41 TÜV Rheinland Commends the State of California Blue Light Resolution; Announces Blue Light Summit With Electronics Manufacturers
2019-10-10 16:29 Galderma Advances Phase 3 Clinical Study with Nemolizumab in Moderate-to-Severe Atopic Dermatitis
2019-10-10 13:55 Professional Triathletes Organisation Responds to Wanda Sports Board’s Decision Declining to Enter Into Discussions to Sell Ironman® Business
2019-10-10 09:28 ABB Demonstrates Concept of Mobile Laboratory Robot for Hospital of the Future
2019-10-09 18:35 Fujifilm to Sponsor the World Marketing Summit 2019, Organized by Professor Philip Kotler, as Global Partner, and to Launch a Special Interview Website
2019-10-09 14:14 Samsung Bioepis Presents Real-world Data of BENEPALI™ (etanercept) in Patients with Psoriasis at European Academy of Dermatology and Venereology (EADV) Congress
2019-10-09 09:38 Adlai Nortye Presents Encouraging Phase 1b Study Data of AN0025 (an Oral EP4 Antagonist) for Locally Advanced Rectal Cancer at ESMO 2019
2019-10-08 20:20 The Estée Lauder Companies Unites the World in Hope With Its 2019 Breast Cancer Campaign
2019-10-08 13:13 Hong Kong International Optical Fair Opens in November
2019-10-08 12:03 MPEG LA Announces Peer Reviewed Article Featured in Nucleic Acid Therapeutics
2019-10-08 10:58 Update of Summary of Product Characteristics for Nuwiq® includes data on effective bleed protection with twice-weekly dosing with personalised prophylaxis
2019-10-08 08:09 New data reinforces benefits of Spiolto® Respimat® in improving patient outcomes
2019-10-08 08:07 Servier acquires non-Hodgkin B-cell lymphoma treatment PIXUVRI® (pixantrone) from CTI BioPharma, strengthening the Servier oncology portfolio
2019-09-30 14:48 INBUILD® meets primary endpoint - study evaluated nintedanib in patients across a range of progressive fibrosing interstitial lung diseases1
2019-09-30 11:29 TÜV Rheinland: Notified Body for the New Medical Device Regulation
2019-09-30 09:20 Clover Biopharmaceuticals Doses First Patient in Phase I Study of SCB-313 in China for Malignant Ascites
2019-09-27 14:18 New Data Presented at World Sleep Congress Demonstrate Early Signs of Efficacy for TAK-925, a Selective Orexin Type-2 Receptor (OX2R) Agonist, in Patients with Narcolepsy Type 1
2019-09-27 11:50 TÜV Rheinland: Is Nylon Safe Enough to Be a Food Contact Material?
2019-09-27 09:34 Samsung Bioepis Announces Phase 3 Results of SB8, Bevacizumab Biosimilar Candidate, at the European Society for Medical Oncology (ESMO) 2019 Congress

Business Wire Weibo

Press Releases

Latest Releases